https://www.nice.org.uk/guidance/ta1013/chapter/5-Evaluation-committee-members-and-NICE-project-team
Evidence-based recommendations on quizartinib (Vanflyta) for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute...
evaluation committeeproject teammembersnicequizartinib